Reshape Lifesciences Inc
(RSLS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 11,299 | 15,089 | 607 | 569 | 787 |
| Cost of Goods | 5,037 | 5,784 | 164 | 333 | 432 |
| Gross Profit | 6,262 | 9,305 | 443 | 236 | 355 |
| Operating Expenses | 18,756 | 34,550 | 39,153 | 28,623 | 23,582 |
| Operating Income | -12,457 | -24,461 | -38,546 | -28,054 | -22,796 |
| Interest Expense | 2,049 | 451 | 12 | 3 | 4,104 |
| Other Income | -7,305 | -50,188 | -156 | -4,722 | 3,539 |
| Pre-tax Income | -21,811 | -75,100 | -38,714 | -32,779 | -23,361 |
| Income Tax | -181 | -893 | -3,447 | -2,315 | N/A |
| Net Income Continuous | -21,630 | -74,207 | -35,267 | -30,464 | -23,361 |
| Net Income Discontinuous | N/A | N/A | -45,885 | -3,354 | N/A |
| Net Income | $-21,630 | $-74,207 | $-81,152 | $-33,818 | $-23,361 |
| EPS Basic Total Ops | -3.12 | -42.93 | -9,023.14 | -776,234.90 | -37.53 |
| EPS Basic Continuous Ops | -3.12 | -42.93 | -4,107.77 | -699,257.80 | -37.53 |
| EPS Basic Discontinuous Ops | N/A | N/A | -4,915.37 | -76,977.11 | N/A |
| EPS Diluted Total Ops | -3.12 | -42.93 | -9,023.14 | -776,234.90 | -37.53 |
| EPS Diluted Continuous Ops | -3.12 | -42.93 | -4,107.77 | -699,257.80 | -37.53 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -4,915.37 | -76,977.11 | N/A |
| EPS Diluted Before Non-Recurring Items | -3.12 | -6.73 | -1,201.21 | -809,030.50 | N/A |
| EBITDA(a) | $-9,093 | $-16,167 | $-24,101 | $-27,786 | $-20,820 |